Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.46 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 2/20 | 0.42 |
| ▸ | RIN1 | Q13671 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
| ▸ | PTGER4 | P35408 | 7/20 | 0.39 |
| ▸ | PTGER3 | P43115 | 6/20 | 0.39 |
| ▸ | PTGER2 | P43116 | 5/20 | 0.39 |
| ▸ | PER2 | O15055 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4635213 | 0.94 | CHRM2 (0.45) | MEN1KMT2APOLBCHRM2CHRM4 | |
| SCHEMBL665342 | 0.93 | PTGER4 (0.46) | MEN1KMT2APOLBCHRM2CHRM4 | |
| SCHEMBL664674 | 0.93 | PTGER4 (0.46) | MEN1KMT2APOLBCHRM2CHRM4 | |
| SCHEMBL4329362 | 0.93 | PTGER4 (0.46) | MEN1KMT2APOLBCHRM2CHRM4 | |
| SCHEMBL4588711 | 0.93 | PTGER4 (0.46) | MEN1KMT2APOLBCHRM2CHRM4 | |
| SCHEMBL664648 | 0.93 | PTGER4 (0.46) | MEN1KMT2APOLBCHRM2CHRM4 | |
| SCHEMBL30697351 | 0.93 | PTGER4 (0.46) | MEN1KMT2APOLBCHRM2CHRM4 | |
| SCHEMBL4588206 | 0.93 | PTGER4 (0.46) | MEN1KMT2APOLBCHRM2CHRM4 | |
| SCHEMBL4588299 | 0.93 | PTGER4 (0.46) | MEN1KMT2APOLBCHRM2CHRM4 | |
| Methane SCHEMBL4593708 | 0.93 | CHRM2 (0.44) | MEN1KMT2APOLBCHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116422367-B | Zirconium-silicon molecular sieve encapsulated platinum sub-nanoparticle catalyst and preparation method and application thereof | 天津师范大学 | 2025-01-28 | — | — | CN | claimed |
| CN-117897439-A | Method for screening solvent for extraction of polyvinyl chloride, method for recovering waste material, and recovered polyvinyl chloride and composition | 株式会社LG化学 | 2024-04-16 | — | — | CN | claimed |
| CN-116422367-A | Zirconium-silicon molecular sieve encapsulated platinum sub-nanoparticle catalyst and preparation method and application thereof | 天津师范大学 | 2023-07-14 | — | — | CN | claimed |
| CN-116422367-B | Zirconium-silicon molecular sieve encapsulated platinum sub-nanoparticle catalyst and preparation method and application thereof | 天津师范大学 | 2025-01-28 | — | — | CN | disclosed |
| CN-116550362-B | FeNi@NC bimetallic catalyst and preparation method and application thereof | 浙江工业大学 | 2024-12-10 | — | — | CN | disclosed |
| CN-115709077-B | Method for preparing 5-methyl-N-substituted pyrrolidone compound | 中国科学院广州能源研究所 | 2024-06-28 | — | — | CN | disclosed |
| CN-117897439-A | Method for screening solvent for extraction of polyvinyl chloride, method for recovering waste material, and recovered polyvinyl chloride and composition | 株式会社LG化学 | 2024-04-16 | — | — | CN | disclosed |
| CN-117897440-A | Method for screening solvent for extraction of polyvinyl chloride, method for recycling waste material, recycled polyvinyl chloride and composition | 株式会社LG化学 | 2024-04-16 | — | — | CN | disclosed |
| CN-116550362-A | FeNi@NC bimetallic catalyst and preparation method and application thereof | 浙江工业大学 | 2023-08-08 | — | — | CN | disclosed |
| CN-116422367-A | Zirconium-silicon molecular sieve encapsulated platinum sub-nanoparticle catalyst and preparation method and application thereof | 天津师范大学 | 2023-07-14 | — | — | CN | disclosed |
| US-20230167545-A1 | STABILIZATION OF CARBON DEPOSITION PRECURSORS LIKE C2H2 | LAM RESEARCH CORPORATION | 2023-06-01 | — | — | US | disclosed |
| US-8026273-B2 | 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2011-09-27 | — | — | US | disclosed |
| WO-2011054387-A1 | COSMETIC COMPOSITIONS COMPRISING AN ESTER DERIVED FROM 4-CARBOXY-2-PYRROLIDINONE AND A MEROCYANIN SCREENING AGENT; USE OF SAID DERIVATIVE AS A SOLVENT FOR A MEROCYANIN SCREENING AGENT | L'OREAL (FR) | 2011-05-12 | — | — | WO | disclosed |
| US-20100143276-A1 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions | L'OREAL (FR) | 2010-06-10 | — | — | US | disclosed |
| US-20100113388-A1 | 8-AZAPROSTAGLANDIN DERIVATIVE COMPOUND AND AGENT COMPRISING THE COMPOUND AS ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-05-06 | — | — | US | disclosed |
| US-7683094-B2 | 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-03-23 | — | — | US | disclosed |
| US-20090042885-A1 | 8-AZAPROSTAGLANDIN DERIVATIVE COMPOUND AND AGENT COMPRISING THE COMPOUND AS ACTIVE INGREDIENT | ONO PHARMACEUTICAL CO., LTD. (JP) | 2009-02-12 | — | — | US | disclosed |
| EP-2004744-A1 | COMPOSITION INCLUDING MULTIPLE FUNCTIONALIZED POLYMERS | Bridgestone Corporation (JP) | 2008-12-24 | — | — | EP | disclosed |
| US-7402605-B2 | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2008-07-22 | — | — | US | disclosed |
| WO-2007120797-A1 | COMPOSITION INCLUDING MULTIPLE FUNCTIONALIZED POLYMERS | BRIDGESTONE CORPORATION (JP) | 2007-10-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042885-A1 | 8-AZAPROSTAGLANDIN DERIVATIVE COMPOUND AND AGENT COMPRISING THE COMPOUND AS ACTIVE INGREDIENT | PTGER2, PTGIS, HPGDS | MEN1 3441/4885KMT2A 4644/4885POLB 2542/4885 |
| US-20100143276-A1 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions | FASN, ALOX12, PAH | MEN1 2738/4885KMT2A 2116/4885POLB 436/4885 |
| US-20100113388-A1 | 8-AZAPROSTAGLANDIN DERIVATIVE COMPOUND AND AGENT COMPRISING THE COMPOUND AS ACTIVE INGREDIENT | PTGER2, PTGIS, HPGDS | MEN1 3441/4885KMT2A 4644/4885POLB 2542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.